Australian TGA approves additional indication for Telix's Illuccix® to include patient selection for PSMA-Targeted ...

A new treatment for early to mild Alzheimer’s disease has been registered with Australia’s pharmaceutical regulator, the ...

Biotech innovator NeuroScientific Biopharmaceuticals has received the green light from Australia’s drugs regulator to treat ...

Regulators focused on pragmatic safety messaging this week, with aligned statements that paracetamol remains appropriate in ...

But while lecanemab has been shown to slow the progression of disease in some people who receive an early diagnosis, it comes ...

A new study shows longer-term use of generic ketamine for severe depression is safe and effective, but researchers say access ...

Dementia is a condition that results in progressive memory or thinking problems. It's now the most common cause of death in ...

One of the world's first clinical trials into the potential for psychedelic compound psilocybin to prevent disabling cluster ...

The Trump administration is expected to announce on Monday that pregnant women’s use of Tylenol – widely known as paracetamol ...

Doctors and nurses working for telehealth companies must ensure patients who use a chatbot or AI to talk about their care ...